Compare OGN & WTTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OGN | WTTR |
|---|---|---|
| Founded | 1923 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oilfield Services/Equipment |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | 2020 | 2017 |
| Metric | OGN | WTTR |
|---|---|---|
| Price | $5.85 | $15.55 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $11.75 | ★ $16.17 |
| AVG Volume (30 Days) | ★ 3.0M | 1.3M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | 1.32% | ★ 1.80% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | ★ $6,216,000,000.00 | $1,528,930,000.00 |
| Revenue This Year | $0.42 | $2.32 |
| Revenue Next Year | $1.67 | $5.14 |
| P/E Ratio | ★ $8.42 | $69.16 |
| Revenue Growth | N/A | ★ 120.79 |
| 52 Week Low | $5.76 | $7.20 |
| 52 Week High | $14.94 | $15.66 |
| Indicator | OGN | WTTR |
|---|---|---|
| Relative Strength Index (RSI) | 25.56 | 70.32 |
| Support Level | N/A | $10.10 |
| Resistance Level | $7.87 | N/A |
| Average True Range (ATR) | 0.22 | 0.51 |
| MACD | 0.00 | 0.09 |
| Stochastic Oscillator | 10.00 | 91.87 |
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
Select Water Solutions Inc provides sustainable water-management solutions to the energy industry in the United States. These solutions are supported by the company's critical water infrastructure assets, chemical manufacturing, and water treatment and recycling capabilities. The company's reportable segments are Water Services, Water Infrastructure, and Chemical Technologies. It generates maximum revenue from the Water Services segment, which comprises its short-cycle, field-based service offerings, including water transfer, water sourcing, fluids hauling, monitoring, containment, water-network automation, and the services associated with Peak Rentals. This segment earns revenue via market-based day rates, time-and-materials, or per-barrel delivered under MSAs and short-term work orders.